Cargando…

MON-002 The Effect of GNRHR Autoantibody on Reproduction Function and Insulin Signaling Intermediates in a New Animal Model of Polycystic Ovary Syndrome

Background: Polycystic ovary syndrome (PCOS), a metabolic and reproductive associated disease, defined as hyperandrogenism with reproductive dysfunction including menstrual disorder, anovulation, infertility, polycystic ovary and so on. We previously showed reported a high percentage of activating a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hongliang, Guo, Yankai, Zhang, Gege, Deng, Jielin, Fischer, Hayley, Craig, LaTasha B, Yu, Xichun, Kem, David C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208854/ http://dx.doi.org/10.1210/jendso/bvaa046.1934

Ejemplares similares

SUN-LB5 GnRHR ECL-2 Epitopes Targeted by Activating Autoantibodies in Polycystic Ovary Syndrome
por: Guo, Yankai, et al.
Publicado: (2020)

The Role of GnRH Receptor Autoantibodies in Polycystic Ovary Syndrome
por: Kem, David C, et al.
Publicado: (2020)

Autoimmune activation of the GnRH receptor induces insulin resistance independent of obesity in a female rat model
por: Li, Hongliang, et al.
Publicado: (2020)

Elevated activity levels of activating autoantibodies to the GnRH receptor in patients with polycystic ovary syndrome
por: Weedin, Elizabeth A., et al.
Publicado: (2020)

Low-level tragus stimulation improves autoantibody-induced hyperadrenergic postural tachycardia syndrome in rabbits
por: Guo, Yankai, et al.
Publicado: (2022)

MON-030 Intermediate Hyperglycemia and Type 2 Diabetes in Women with Polycystic Ovary Syndrome: Findings from Large Caucasian Cohort
por: Livadas, Sarantis, et al.
Publicado: (2020)

MON-205 Is Muscle Mechanical Function Altered In Polycystic Ovary Syndrome?
por: Caliskan Guzelce, Ezgi, et al.
Publicado: (2019)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

MON-207 Identification of Monogenic Causes of Polycystic Ovary Syndrome by High Throughput Sequencing
por: Crespo, Raiane, et al.
Publicado: (2019)

MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity
por: Maidana, Patricia Nieves Amelia, et al.
Publicado: (2020)

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

MON-234 Targeted Profiling of Plasma MicroRNAs in Women with Polycystic Ovary Syndrome (PCOS): Impact of Obesity
por: Almawi, Wassim, et al.
Publicado: (2019)

MON-211 The Negative Impact of Polycystic Ovary Syndrome in Bone Health: A Systematic Review and Meta-Analysis
por: Piovezan, Julia, et al.
Publicado: (2019)

MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
por: Rodriguez Paris, Valentina, et al.
Publicado: (2019)

MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature
por: Shirin, Sonia, et al.
Publicado: (2020)

MON-214 The Natural Course of Normal Weight Women with Polycystic Ovary Syndrome: An Insight into Metabolic Changes of Large Caucasian Cohort
por: Livadas, Sarantis, et al.
Publicado: (2019)

MON-LB038 Reduced Exercise Endurance And Skeletal Muscle Alterations In A Prenatally Androgenized Rat Model For Polycystic Ovary Syndrome
por: DeChick, Auryana, et al.
Publicado: (2019)

MON-042 The Effect of Exercise Training on Reproductive and Cardiometabolic Outcomes in Women with Polycystic Ovary Syndrome: A Pilot Randomized Controlled Trial
por: Benham, Jamie L, et al.
Publicado: (2020)

MON-029 Polycystic Ovary Syndrome (PCOS) in Adolescent Girls:Toward a Simple On-Treatment Predictor of Post-Treatment Ovulation Rate
por: Ibanez, Lourdes, et al.
Publicado: (2020)

MON-LB9 Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS) - Person-Related 6-Month Experience Changes
por: Shirin, Sonia, et al.
Publicado: (2020)

MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome
por: Legro, Richard, et al.
Publicado: (2019)

MON-043 Sleep Disturbances in Women with and Without Polycystic Ovary Syndrome (PCOS) and Their Association with Lifestyle Factors (Diet, Physical Activity and Sitting Time)
por: Bennett, Christie, et al.
Publicado: (2020)

MON-LB002 Compounded Testosterone Preparations Raise Testosterone Levels to Premenopausal Ranges in Postmenopausal Women With Hypo-Sexual Desire Disorder (HSDD)
por: Olson, Beatriz Rodriguez
Publicado: (2020)

MON-232 Differential Regulation of Genes Relevant to Reproductive Function in Human Granulosa Cells of Small Antral Follicles from Women with or without Polycystic Ovary Syndrome
por: Owens, Lisa, et al.
Publicado: (2019)

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology
por: Kazemi, Maryam, et al.
Publicado: (2019)

Role of Single Nucleotide Variants in FSHR, GNRHR, ESR2 and LHCGR Genes in Adolescents with Polycystic Ovary Syndrome
por: Lidaka, Lasma, et al.
Publicado: (2021)

MON-040 11-Oxygenated C19 Steroids in Polycystic Ovarian Syndrome
por: Mody, Armaiti, et al.
Publicado: (2020)

OR35-03 Uncovering Causative Mutations in Polycystic Ovary Syndrome
por: Srivastava, Jaya, et al.
Publicado: (2023)

FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome
por: Husby, Anne Engtrø, et al.
Publicado: (2023)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

SUN-018 No Difference in Breastfeeding Rates in Women with Polycystic Ovary Syndrome
por: Bui, Leeann, et al.
Publicado: (2020)

FRI457 Protein-coding Genetic Variation In Polycystic Ovary Syndrome
por: Parker, Chloe, et al.
Publicado: (2023)

OR35-06 Polycystic Ovary Syndrome Is Associated With an Increased Mortality Risk
por: Ollila, Meri-Maija, et al.
Publicado: (2023)

Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance
por: Genazzani, Alessandro D, et al.
Publicado: (2023)

Adrenergic Autoantibody‐Induced Postural Tachycardia Syndrome in Rabbits
por: Li, Hongliang, et al.
Publicado: (2019)

MON-210 Diagnostic Concordance of Hemoglobin A1c for Insulin Sensitivity Testing in Polycystic Ovarian Syndrome
por: Garvin, Sicily, et al.
Publicado: (2019)

SAT-024 Investigating Racial and Ethnic Comorbidity Patterns of Polycystic Ovary Syndrome
por: Actkins, Ky’Era, et al.
Publicado: (2020)

Genetic Sex Effects of Polycystic Ovary Syndrome Reveal Distinct Metabolic Etiology
por: Actkins, Ky’Era, et al.
Publicado: (2021)

OR15-5 Cognitive Function in Reproductive Aged Individuals with Polycystic Ovary Syndrome
por: Cedars, Marcelle, et al.
Publicado: (2022)

SAT370 Economic Burden of Endometrial Cancer Associated with Polycystic Ovary Syndrome
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j8nj34hm1u8msu71svk1ar5f50